Polypeptide Group

Switzerland
Baar, Zug, Switzerland

Company profile

Polypeptide Group company profile

The PolyPeptide Group is a contract manufacturing organization for peptides and peptide related molecules. A global presence throughout the world assures our clients a reliable supply with the necessary capacity for an uninterrupted service. The Group is one of the world’s largest independent contract manufacturers of therapeutic peptides for the cosmetic, pharmaceutical and veterinary markets employing more than 450 people in six manufacturing sites located in France, India, Scandinavia and the USA. PolyPeptide Group is privately-held organization that manufactures over one third of all approved peptide drug substances (22 of 62 approved products worldwide) accounting for over 25% of the sales of outsourced peptide therapeutics worldwide.

Business identity

Contact email
[email protected]
Phone number
+46 40 366 200
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$10M-$100M
Founded
1996-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Last funding
Post IPO Debt / $45.5M / 2025-05-23
Investors
3
Articles
40
Exited on
2021-04-29

Categories and groups

Founders and investors

Investors

Danske BankDraupnir HoldingZürcher Kantonal Bank